RISK WARNING: Your capital is at risk. The risks of investing include: illiquidity; lack of dividends; loss of investment; and dilution. You should invest only as part of a diversified portfolio.
Please read FULL risk warning
Bioinduction aims to make neurostimulation as mainstream as cardiac pacemakers are today: Stimulating the nervous system to replace drugs.
CAUTION: This project has not been approved as a financial promotion. No investment decisions about the project should be made on the basis of information provided on this platform.
This company has not shared it's twitter feed.
Our mission is:
- To disrupt Deep Brain Stimulation (DBS) markets through the introduction of the Picostim technology, a neurostimulator 60% smaller than competitors and capable of implantation in around half the time.
- To leverage efficiency savings engendered by such a device by expanding into indications of scale such as drug resistant hypertension, stroke and vascular dementia, currently with high unmet need and targeted near-exclusively by Pharma.
Originator: SETsquared Partnership
Investment Focus: Equity
About: The SETsquared Partnership is the enterprise collaboration between the universities of Bath, Bristol, Exeter, Southampton and Surrey.
Contact Name: Jake Ronay
Registered Investors100 - 250
Investment through platformUp to £1m